Top Purchase Related
Home
>
Node
>
Subnode

Pathology of cancer of the breast

Mao, P.

Arizona Medicine 32(4): 303-312

1975

ISSN/ISBN: 0004-1556
PMID: 164164
Document Number: 85702

Document emailed within 1 workday
Secure & encrypted payments

1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Prechtel, K.; Gehm, O. 1975: Pathology of pre- and early stages of breast cancer Verhandlungen der Deutschen Gesellschaft für Pathologie 59: 498
Kochar, S.; Arora, P.; Chattopadhyay, A.B. 2005: Tamoxifen Therapy for Breast Cancer and Endometrial Pathology Medical Journal Armed Forces India 61(4): 313-315
Rilke, F.; Andreola, S.; Carbone, A.; Clemente, C.; Pilotti, S. 1978: The importance of pathology in prognosis and management of breast cancer Seminars in Oncology 5(4): 360-372
Agromayor Arredondo, R.; Hernández Guimera, L.; Colmenar Rodríguez, L.; Benavides García, P. 1979: Breast pathology findings in the prevention of female cancer in 15,500 women Revista de Sanidad E Higiene Publica 53(7-8): 1117-1127
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Ivanova, V.; Karaivanov, M.; Marinov, E.; Gorchev, G.; Velkova, A.; Khristova, P. 2003: Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex) Akusherstvo i Ginekologiia 42(5): 3-8
Hauser, H.; Beham, A.; Steindorfer, P.; Smola, M.G.; Fruhwirth, H.; Klimpfinger, M. 1992: Breast cancer in the catchment area of the Graz Institute of Pathology. Evaluation of morphologic parameters based on 1,510 cases Wiener Klinische Wochenschrift 104(23): 717-720
Balaton, A.L.; Coindre, J.M.; Collin, F.; Ettore, F.; Fiche, M.; Jacquemier, J.; Le Doussal, V.; Mandard, A.M.; Mathieu, M.C.; Migeon, C.; Simony-Lafontaine, J.; Treilleux, I.; Verriele, V.; Vilain, M.O.; Zafrani, B. 1996: Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology Annales de Pathologie 16(2): 144-148
Marchevsky, A.M.; Shah, S.; Patel, S. 1999: Reasoning with uncertainty in pathology: artificial neural networks and logistic regression as tools for prediction of lymph node status in breast cancer patients Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 12(5): 505-513
Cserni, G. 1998: Prognosis in breast cancer based on histopathological findings (based on data from 42 pathology departments) Orvosi Hetilap 139(47): 2819-2827
Hammond, E.H.; Flinner, R.L. 1997: Clinically relevant breast cancer reporting: using process measures to improve anatomic pathology reporting Archives of Pathology and Laboratory Medicine 121(11): 1171-1175
Bogomoletz, W.V. 1994: Cystic hypersecretory hyperplasia of the breast. a rare diagnosis in breast pathology Annales de Pathologie 14(2): 131-132
Kaufman, Z.; Shapira, M.; Dinbar, A. 1993: Changes in diagnosis and treatment of breast pathology at a specialized breast clinic Harefuah 124(8): 464-8 528 527
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Mariuzzi, L.; Mombello, A.; Rucco, V.; Morelli, L.; Zamò, A.; Thompson, D.; Vaught, L.; Bartels, H.G.; Mariuzzi, G.; Bartels, P.H. 2000: Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer Advances in Clinical Pathology: the Official Journal of Adriatic Society of Pathology 4(2): 87-97
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280